SCHEMBL13348223

SCHEMBL13348223

O=CCCc1ccc(OCc2cccc3c2N(S(=O)(=O)c2ccccc2)CCC3)cc1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.43
PTGER2 P43116 2/20 0.41
KMT2A Q03164 2/20 0.39
RORC P51449 2/20 0.38
AKR1C3 P42330 1/20 0.38
NR1H3 Q13133 1/20 0.38
PTGER4 P35408 1/20 0.37
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP7 P09237 1/20 0.37
MMP9 P14780 1/20 0.37
MMP12 P39900 1/20 0.37
MMP14 P50281 1/20 0.37
MMP15 P51511 1/20 0.37
MMP16 P51512 1/20 0.37
MMP26 Q9NRE1 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13312060 0.88 RXRA (0.47) HRH3PTGER2KMT2ARORCAKR1C3
SCHEMBL13348399 0.85 RXRG (0.47) HRH3PTGER2KMT2ARORCAKR1C3
SCHEMBL13348224 0.85 PTGER4 (0.46) PTGER2PTGER4
SCHEMBL13348225 0.84 LTA4H (0.35) PTGER2PTGER4
SCHEMBL3503290 0.83 PTGER2 (0.43) HRH3PTGER2KMT2ARORCAKR1C3
SCHEMBL13348046 0.82 PTGER2 (0.37) PTGER2KMT2ARORCPTGER4MMP1
SCHEMBL13348107 0.82 PTGER4 (0.44) HRH3PTGER2PTGER4
SCHEMBL13312546 0.82 PTGER2 (0.48) PTGER2RORCAKR1C3PTGER4MMP1
SCHEMBL13348138 0.81 HPD (0.41) PTGER2PTGER4LMNA
SCHEMBL13348415 0.81 TSHR (0.43) PTGER2RORCPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES ASTELLAS PHARMA INC. (JP) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES GPR119, GPR65, HCAR1 HRH3 573/4885PTGER2 3346/4885KMT2A 3440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.